Trial intelligence / Profile preview

Guided immunonutrition with L-arginine in non-surgical intensive care

2009-014437-24Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Aug 2009
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 3, randomised trial in critical illness and Healthcare-associated infection (HAI) comparing L-arginine immunonutrition with Placebo (2 arms). Primary endpoints: Nasal nitric oxide concentration, Monocyte HLA-DR expression and 5 more. Started Aug 2009; status: active.

02

Drugs

arginine
03

Conditions

critical illnessHealthcare-associated infection (HAI)

Beyond the preview

Go deeper on 2009-014437-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014437-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call